Reynolds later joined Lilly’s Cardiac Pacemaker, Inc. division spending 13 years in sales leadership positions in cardiac rhythm management. He additionally held a leadership position in Guidant Corporation’s Corporate Account program, working with the cardiac rhythm management, interventional cardiology and minimally invasive surgery divisions. When Guidant was acquired by Boston Scientific in 2006, Reynolds held corporate sales director and vice president positions in Boston’s Corporate Sales program, working with their cardiac rhythm management, interventional cardiology, endoscopy, urology and neuromodulation divisions.
“We’re very excited to add Pat to our senior management team,” said Jay Ethridge, chief executive officer of IPG. “He has a wealth of experience in developing and building a technical and clinically focused sales and service organization in the implantable device market, which will bring great value to all of IPG?s stakeholders.”
“Pat has developed relationships with numerous electrophysiologists, cardiologists and administrators across the country throughout his extensive career in the healthcare industry,” continued Ethridge. “His knowledge brings a new dimension and insight to IPG, allowing us to continue to provide the highest level of service to our clients.”
